Business Wire

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Share

Engelhart Commodities Trading Partners, a global commodities trading business, is delighted to announce that it has agreed terms to acquire Trailstone, a global energy and technology company, from Riverstone.

Completion of the acquisition, which remains subject to regulatory approval, is expected to occur in Q3, 2024.

The deal is a significant event for both companies, as it represents a shared commitment to ensuring the success of the clean energy transition. The transaction not only strengthens their trading and technological capabilities, but also generates value through active support of a sustainable future.

Trailstone is a global leader in the provision of risk management and optimization services to the owners and operators of renewable power generation assets, by utilising its expertise, analytics and proprietary software. It is also active in trading power, natural gas and environmental products across North America, Europe and Asia.

The team at Trailstone has also built a successful physical natural gas client business in North America, which provides storage, transportation and supply capabilities to serve its customers' growing optimization and risk management requirements.

The acquisition will combine the resources and expertise of two successful businesses and enable them to leverage their joint capabilities to enhance trading performance, grow their customer business and play a leading role in decarbonising the world’s energy matrix.

The acquisition is a pivotal part of Engelhart’s strategic plan to strengthen its global power and gas trading platform and technology capabilities and generate value through active participation in the clean energy transition.

Huw Jenkins, Engelhart CEO, says the acquisition is a clear signal of Engelhart’s commitment to the clean energy transition:

“Agreeing terms to acquire Trailstone is an important event in Engelhart’s long term strategy to grow our energy trading platform and enhance our technological capability to play a leading role in the clean energy transition. We have been impressed by the Trailstone team’s innovation in the renewables trading sector and we believe the acquisition and merger will be highly complementary for both businesses.”

John Redpath, CEO, Trailstone, says he’s excited about the potential that this acquisition unlocks:

“The acquisition by Engelhart is a big moment for the future of Trailstone. The access to permanent capital, and the complementary nature of our two organizations means we can grow our renewables and power & natural gas businesses and create even more value as part of the clean energy transition. I am proud of what we've created at Trailstone over the last ten years, not because it was easy but because it was hard. I am even more positive and excited about the future as we move forward as one business. I've been in the energy markets for 35 years, and I think the most interesting years of my career are ahead as we build this combined business.”

FOR EDITORS

  • The acquisition has been agreed but remains subject to regulatory approval.
  • Latham & Watkins LLP acted as legal advisors to Riverstone and Trailstone. Skadden, Arps, Slate, Meagher & Flom LLP acted as legal advisers to Engelhart Commodities Trading Partners.
  • Engelhart is a global commodity trading company founded in 2013, with ~180 staff across offices in London, Geneva, Houston, Stamford, Singapore, Shanghai and Beijing.
  • Engelhart trades energy (power and gas, and oil) and is also active in agricultural/soft commodities, freight, and the innovative area of ‘risk premia’.
  • Engelhart is owned by the same partner group that also controls BTG Pactual, the largest investment bank in Latin America.
  • Trailstone is a global energy and technology trading company, operating at the intersection of renewable and conventional power. Trailstone provides a best-in-class service to help manage the intermittency of renewable power generation for asset owners, operators and grid infrastructure. Trailstone also offers tech-enabled risk management and asset management optimization solutions for renewables assets across Europe, Japan and the United States. Trailstone was founded in 2013 and has ~275 staff across offices in Europe, North America, and Japan, with its primary offices in London, Austin, and Berlin.
  • Engelhart will acquire Trailstone from Riverstone LLC, the private equity fund that was its primary shareholder, subject to regulatory approval.

  • Huw Jenkins will be the CEO of the new combined business; John Redpath will be Deputy CEO.
  • No decision has yet been made on future naming and branding. For now, just use ‘Engelhart Commodities Trading Partners’, ‘Engelhart’ or ‘Trailstone’ or ‘the combined business’ to describe the relevant parties.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For more information, contact: Cosmo Shield (cosmo@cosmocreativecontent.co.uk)

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

REPLY: AIRA Challenge 2024 Prize awarded to Roboverse Reply for Mobile Robot Control via VR Glasses24.6.2024 11:00:00 EEST | Press release

Roboverse Reply, specialises in integrating Robotics and Reality Capture with Mixed Reality, has won the Advanced Industrial Robotic Applications (AIRA) Challenge for the second time in a row. The competition invited world-leading experts to develop innovative solutions for enabling the remote control of mobile robots during autonomous inspections in production environments. Roboverse Reply’s platform demonstrates how Artificial Intelligence and human expertise can be combined to tackle challenging industrial tasks in real-world applications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240624606163/en/ Roboverse Reply, specialises in integrating Robotics and Reality Capture with Mixed Reality, has won the Advanced Industrial Robotic Applications (AIRA) Challenge for the second time in a row. (Graphic: Business Wire) The final of the AIRA Challenge took place for the second time at ACHEMA, the world's largest trade fair fo

Takeda Announces Approval of LIVTENCITY ® (maribavir) in Japan for Post-Transplant Cytomegalovirus (CMV) Infection/Disease That Is Refractory to Existing Anti-CMV Therapies24.6.2024 10:00:00 EEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that LIVTENCITY® (maribavir) has been approved by the Japanese Ministry of Health, Labour and Welfare (MHLW)for post-transplant cytomegalovirus (CMV) infection/disease that is refractory to existing anti-CMV therapies.4 LIVTENCITY is the first and only post-transplant anti-CMV treatment approved in Japan that targets and inhibits pUL97 kinase and its natural substrates.1 “We are pleased by the approval of LIVTENCITY in Japan, which will provide the transplant community with a new option for treatment of post-transplant CMV infection in patients refractory to other therapies,” said Yasushi Kajii, Head, R&D Japan Region at Takeda. “A diagnosis of CMV infection can be particularly challenging for patients, and serious complications such as increased organ rejection and hospitalization rates can occur, when not successfully treated. We believe LIVTENCITY has the potential to help address the challenges faced by people with post-transplant CMV and

Megaport and Lufthansa Systems Announce Landmark Partnership to Accelerate Airline Digital Transformation24.6.2024 09:00:00 EEST | Press release

Megaport Limited (ASX: MP1) (“Megaport”), the global leading Network as a Service (NaaS) provider, and Lufthansa Systems, a leading aviation IT provider, today announced a new partnership that will accelerate digital transformation in the aviation industry. The strategic partnership will see Lufthansa Systems leverage Megaport’s global Software Defined Network (SDN) to securely and reliably move the global aviation cloud from a single cloud to multiple clouds by moving core routing from cloud to Megaport. Megaport will also facilitate a secure aviation customer landing zone to expedite peering with other airlines and exchanging data. Lufthansa Systems provides IT services to over 350 airlines worldwide. Its Global Aviation Cloud initiative aims to virtualise mission-critical airline applications and transition them to the cloud. Using Megaport’s private connectivity from resilient data centres, virtual firewalls, and virtual routing, Lufthansa Systems can securely and reliably connect

Seroba and Kurma Partners Announce Complementary Series B Funding for Vico Therapeutics totaling €65.8 million ($70.7 million)24.6.2024 09:00:00 EEST | Press release

Seroba, an European life sciences venture capital firm headquartered in Dublin, with offices in Paris and Milan, and Kurma Partners, a key European Venture Capital firm financing innovation in Healthcare and Biotechnology, from pre-seed to growth capital, based in Paris and Munich, announced today the completion of the second closing part of Series B financing round of Vico Therapeutics. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240623484065/en/ Vico Therapeutics B.V. is a clinical-stage genetic medicines company developing therapies for severe neurological diseases. Its lead program VO659 is currently in a Phase 1/2a clinical study of patients with spinocerebellar ataxia types 3 and 1 and Huntington’s disease, devastating neurodegenerative diseases for which there are currently no disease-modifying treatments available. Seroba joined the consortium of investors leading the planned second closing of the Series B financi

Takeda Presents Late-Breaking Data from Phase 2b Study of Mezagitamab, Demonstrating Potential to Transform Treatment of Primary Immune Thrombocytopenia23.6.2024 05:30:00 EEST | Press release

Takeda (TSE:4502/NYSE:TAK) today presented positive results from its Phase 2b, randomized, double-blind, placebo-controlled study evaluating the safety, tolerability and efficacy of mezagitamab (TAK-079) in patients with persistent or chronic primary immune thrombocytopenia (ITP), a rare immune-mediated bleeding disorder. ITP is characterized by the accelerated destruction of platelets in blood, resulting in a decreased platelet count and an increase of bleeding that can be debilitating. These data (Abstract #LB 01.1) were presented at the oral Late-Breakthrough Session at the 32nd Congress of the International Society on Thrombosis and Haemostasis (ISTH) in Bangkok, Thailand. Takeda plans to initiate a global Phase 3 trial of mezagitamab in patients with ITP in the second half of FY2024. The TAK-079-1004 trial (NCT04278924) evaluated three different doses of subcutaneous mezagitamab (100mg, 300mg and 600mg) versus placebo, given once weekly for eight weeks in patients with chronic or

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye